BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$9.95M | -$11.69M | -$21.44M | -$24.82M | -$24.54M | -$31.68M | -$23.00M | -$14.06M | -$5.00M | -$5.08M |
| Net Income | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M | -$31.81M | -$23.25M | -$13.95M | -$4.95M | -$4.98M |
| EPS (Diluted) | $-1.11 | $-2.31 | $-6.00 | $-0.66 | $-0.68 | $-1.07 | — | — | — | — |
| Total Assets | $1.02M | $1.83M | $4.21M | $8.45M | $29.28M | $51.26M | $6.53M | $11.23M | $11.42M | $10.77M |
| Total Liabilities | $11.01M | $9.60M | $9.07M | $11.47M | $9.94M | $15.79M | $18.76M | $6.21M | $5.54M | $864.0K |
| Shareholders' Equity | -$9.98M | -$7.76M | -$4.86M | -$3.02M | $19.34M | $35.46M | -$12.22M | $5.02M | $5.88M | $9.90M |
| Cash & Equivalents | $29.0K | $187.0K | $1.30M | $772.0K | $18.86M | $37.83M | $536.0K | $942.0K | $2.48M | $547.0K |
| Operating Cash Flow | -$6.97M | -$9.09M | -$20.46M | -$19.32M | -$26.27M | -$35.19M | -$11.25M | -$12.39M | -$2.36M | -$5.86M |
| Capital Expenditures | — | — | $18.0K | $29.0K | $330.0K | $378.0K | $473.0K | $369.0K | $180.0K | $103.0K |
| Shares Outstanding | 11.03M | 6.14M | 4.03M | 36.69M | 36.40M | 35.16M | 23.17M | 20.76M | 18.98M | 18.69M |